Herbas VPB

Print
EN | LT
Supplementary protection
LT - Makrocikliniai hepatito C serino proteazės inhibitoriai
EN - MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
SPC
(11) Number of the document C 2340029
(68) Number of the document 2340029
(21) Application number for Supplementary Protection Certificate PA 2015 011
(22) Date of filing the application 2015-03-04
(41) Date of publication of the application 2015-04-27
Date of publication of SPC 2016-12-27
(24) Date of coming into effect of SPC 2029-09-11
Applicant
(71) AbbVie Bahamas Ltd., Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau, BS
Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472, US
Grantee
(73) Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472, US
AbbVie Manufacturing Management Unlimited Company , 70 Sir John Rogerson's Quay, Dublin 2, IE
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/14.982, 2015-01-15
Calculated date of expiry of the SPC
(94) 2030-01-19
Name of the product protected by the basic patent
(95) Paritapreviras
Legal status
SPC lapsed (non-payment of fees for the main patent)
Date of negative decision to issue the SPC 2025-09-10
Last update date 2026-03-17